Tagged with P

Sweden Johan Wäborg, General Manager Nordic countries at Actelion, shares the importance of Sweden for the group due to its world-class healthcare system and community of experts as well as its national quality and health registries which make the country an ideal environment for early launches and follow-up of treatment outcomes.…

Puerto Rico Charil Pabón, Owner & President of Pharma Consulting Corporation (PCC), explains how the decreasing demand for validation services in Puerto Rico prompted the company to expand in new business areas such as the design and installation of laboratory, where PCC is now market leader, as well as enter new markets…

Taiwan Mengchu Wu, CEO of Health Genetech, introduces the innovative precision medicine company as it prepares to transition from a research-positioned provider to a healthcare partner. Wu goes on to offer her insights on the key market trends impacting the emerging field of precision medicine and shares her outlook on the…

Spain Juan Carlos Moro Rodríguez, CEO for the Iberia Cluster with DB Schenker, discusses the company’s plans to expand its reach across all forms of transport, offering logistics solutions rather than logistics products. Mr Rodríguez also lifts the lid on DB Schenker’s plans to grow its position in pharmaceutical logistics and…

Sweden The National Board of Health and Welfare is the public authority responsible for ensuring that people have access to good health and social care on equal terms in Sweden. Its Director-General, Olivia Wigzell, explains how the Board delivers on this mission, in particular through the development of national care guidelines.…

Opinion Krishna Cheriath, chief data officer at BMS, outlines the ways in which AI is already transforming the delivery of healthcare, what modern biopharma companies’ AI innovation agendas should include, and why behavioural change is a key tenet in securing meaningful health outcomes with AI.   As Biopharma increases AI investments,…

China The US FDA has granted orphan drug designation to Shanghai-headquartered biotech CARsgen Therapeutics’ CAR-T cell therapy CT053 for multiple myeloma after positive results were observed in the phase I trial efficacy evaluation.   19 of 24 patients with relapsed and refractory multiple myeloma showed complete response Zonghai Li, CARSgen Therapeutics…

Puerto Rico Puerto Rico has long been known for its pharma manufacturing prowess, but multinational companies are increasingly looking to conduct clinical trials there, thanks to strong institutional support, a strong example set by R&D-focused university spin-off companies, and the island’s unique ethnic profile.   The Hispanic population has been historically underrepresented…

Canada Diabetes Canada’s Jan Hux outlines how her organization has been able to shift from small, local programs to driving change at a much larger level via a ‘collective impact’ approach.   When I encountered the concept of collective impact in the Stanford Social Innovation Review, I realized the possibilities lay…

Algeria Yacine Sellam, president of the Algerian Society for Regulatory Affairs & Pharmacoeconomics, looks at how European countries such as France and Belgium have countered medicine supply shortages and how Algeria can implement these solutions to address its own drug shortage issue.    This situation is not unique to Algeria. Medicine…

Thailand Thailand’s medical devices (medtech) market is projected to grow from USD 1.2 billion in 2016 to 1.7 billion in 2020, representing a CAGR of 8.1%. Made with Visme Infographic Maker  

Thailand The Thai pharma market, one of the largest in the ASEAN region, stood at USD 4.6 billion in size in 2016. A recent report from the Dutch Embassy in Thailand projects that the market will grow to USD 6.3 billion in 2021 and 8.4 billion by 2026. Made with Visme…